My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 534

    1.

    Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.

    Unal M, Yücel I.

    Br J Ophthalmol. 2008 Oct;92(10):1411-4. Epub 2008 Jul 28.PMID: 18662913 [PubMed - indexed for MEDLINE]Related articles

    2.

    Topical cyclosporine in pediatric keratoplasty.

    Cosar CB, Laibson PR, Cohen EJ, Rapuano CJ.

    Eye Contact Lens. 2003 Apr;29(2):103-7.PMID: 12695714 [PubMed - indexed for MEDLINE]Related articles

    3.

    Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.

    Inoue K, Amano S, Kimura C, Sato T, Fujita N, Kagaya F, Kaji Y, Oshika T, Tsuru T, Araie M.

    Jpn J Ophthalmol. 2000 May-Jun;44(3):302-5.PMID: 10913651 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty]

    Inoue K, Amano S, Kimura C, Sato T, Fujita N, Kagaya F, Kaji Y, Oshika T, Tsuru T, Araie M.

    Nippon Ganka Gakkai Zasshi. 1999 Apr;103(4):306-10. Japanese. PMID: 10339976 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty]

    Xi XH, Qin B, Jiang DY.

    Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):627-30. Chinese. PMID: 15804077 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.

    Price MO, Price FW Jr.

    Ophthalmology. 2006 Oct;113(10):1785-90. Epub 2006 Aug 1.PMID: 16884779 [PubMed - indexed for MEDLINE]Related articles

    7.

    Systemic cyclosporin A in high failure risk, repeated corneal transplantation.

    Rumelt S, Bersudsky V, Blum-Hareuveni T, Rehany U.

    Br J Ophthalmol. 2002 Sep;86(9):988-92.PMID: 12185123 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders.

    Ilari L, Daya SM.

    Ophthalmology. 2002 Jul;109(7):1278-84.PMID: 12093650 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients]

    Graupner M, Seitz B, Langenbucher A, Martus P, Blüthner K, Nguyen NX, Wenkel H, Küchle M.

    Klin Monbl Augenheilkd. 2000 Sep;217(3):163-70. German. PMID: 11076347 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clear graft survival and immune reactions following emergency keratoplasty.

    Maier P, Böhringer D, Reinhard T.

    Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):351-9. Epub 2006 Oct 6.PMID: 17024439 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.

    Bourges JL, Lallemand F, Agla E, Besseghir K, Dumont JM, BenEzra D, Gurny R, Behar-Cohen F.

    Mol Vis. 2006 Dec 2;12:1461-6.PMID: 17167400 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    ABO antigen blood-group compatibility and allograft rejection in corneal transplantation.

    Inoue K, Tsuru T.

    Acta Ophthalmol Scand. 1999 Oct;77(5):495-9.PMID: 10551286 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Efficacy of topical cyclosporine A on keratoplasty rejection in rats]

    Zhang W, Pan Z, Zhai C.

    Zhonghua Yan Ke Za Zhi. 2001 Mar;37(2):140-3. Chinese. PMID: 11864411 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.

    Juberías JR, Calonge M, Gómez S, López MI, Calvo P, Herreras JM, Alonso MJ.

    Curr Eye Res. 1998 Jan;17(1):39-46.PMID: 9472469 [PubMed - indexed for MEDLINE]Related articles

    15.

    Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.

    Birnbaum F, Böhringer D, Sokolovska Y, Sundmacher R, Reinhard T.

    Transplantation. 2005 Apr 27;79(8):964-8.PMID: 15849551 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.

    Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, Martus P, Naumann GO.

    Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):580-4. Epub 2002 Jun 21.PMID: 12136292 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty]

    Bailly N, Dunewa I, Schlattmann P, Rieck PW.

    Ophthalmologe. 2008 May;105(5):457-62. German. PMID: 18299847 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial.

    Kelly D, Jara P, Rodeck B, Lykavieris P, Burdelski M, Becker M, Gridelli B, Boillot O, Manzanares J, Reding R.

    Lancet. 2004 Sep 18-24;364(9439):1054-61.PMID: 15380964 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tacrolimus immunosuppression in high-risk corneal grafts.

    Joseph A, Raj D, Shanmuganathan V, Powell RJ, Dua HS.

    Br J Ophthalmol. 2007 Jan;91(1):51-5. Epub 2006 Sep 6.PMID: 16956911 [PubMed - indexed for MEDLINE]Related articles

    20.

    Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection.

    Wang M, Lin Y, Chen J, Liu Y, Xie H, Ye C.

    Yan Ke Xue Bao. 2002 Sep;18(3):160-4.PMID: 15510746 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity